Books & Magazines
Indian drugmakers Serum Institute of India and Panacea Biotec have submitted their responses to the Indian Council of Medical Research (ICMR) for an Expression of Interest (EOI) to collaborate on Phase 3 clinical trials for India's first dengue vaccine.
17 May 2023
Context:
Indian drugmakers Serum Institute of India and Panacea Biotec have submitted their responses to the Indian Council of Medical Research (ICMR) for an Expression of Interest (EOI) to collaborate on Phase 3 clinical trials for India’s first dengue vaccine.
About Dengue:
News Source: The Hindu
.png)
Connect with our experts to get free counselling & start preparing
Download Our App
Download Our App
<div class="new-fform">
</div>
GS Foundation
Optional Course
Combo Courses
Degree Program
